ArticleEpilepsia2026
Targeting Hsp90 with cemdomespib reduces seizure burden and alters disease course in preclinical epilepsy models.
Yara Sheeni et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it